IDIX up 4.85% after other 10% owner buy.
(EMAILWIRE.COM, February 26, 2011 ) Boston, MA - NOVARTIS PHARMA AG, other 10% owner of IDENIX PHARMACEUTICALS INC (NasdaqGM: IDIX) bought 20,993 shares of IDIX from the open market on 2011-02-25 according to an SEC filing reported by at 2011-02-25 10:49:18 ET. The stock was up 4.85% after the report.

Trade amount: 20,993 Shares
Trade type: Open Market Buy
Price Range: $2.41-$5.11

Transaction details can be found at You can also get real-time alert on any insider trading information from, one step before everybody else.

About is a leading real-time insider trading information provider. is the online division of InsiderCow, a privately-owned company specialized in insider trading information. InsiderCow uses its proprietary software to gather and analyze information provided by the U.S. Securities and Exchange Commission, in real-time. For more information about, visit

About IDIX:
Idenix Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of drugs for the treatment of human viral and other infectious diseases in the United States and Europe.

Disclosure: is not a registered investment advisers or broker/dealer. makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable.


Kevin Leng

This is a press release. Press release distribution and press release services by EmailWire.Com:

Source: EmailWire.Com
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here